Capsules are the second most common form of dosage for the oral administration of drugs after tablets. These are largely used in the nutraceutical and pharmaceutical sectors. Reduction in the timelines of drug development under standard conditions has been the key factor driving the production of drugs delivered in the form of capsules among pharmaceutical and nutraceutical manufacturers. In addition, this strategy enables pharmaceutical manufacturers to reduce the time required to introduce the drug in the market. The other advantage includes protection of a drug substance from various external factors, such as natural or artificial light during production, storage, administration, and use. Furthermore, capsules act as an efficient shield, which prevents the enclosed drugs from decomposition.
The global empty capsules market was valued at $1,841.5 million in 2017 and is projected to reach $3,707.5 million by 2025 growing at a CAGR of 9.1% from 2018 to 2025. Among raw materials, the pig meat segment accounted for three-sevenths share of the total market in 2017.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/985
Based on the product, the global empty capsules market is classified
into gelatin capsules and non-gelatin capsules. Gelatin capsules are further
bifurcated into hard gelatin capsules (HGCs) and soft gelatin capsules (SGCs).
The gelatin segment dominated the global market in 2017 and is expected to
maintain this trend throughout the forecast period. Gelatin has been the
standard choice of raw material for the development of hard shell capsules that
can efficiently hold active pharmaceutical ingredients (APIs). Whereas, the
non-gelatin capsules segment are expected to grow at the fastest pace from 2018
to 2025. An increase in demand for hydroxypropyl methylcellulose (HPMC)
capsules is the major contributor to the robust CAGR of the non-gelatin capsules
segment in the global market. Furthermore, a major shift in consumer behavior
has been observed toward the use of vegetarian capsules in the recent years.
Based on therapeutic application, the market is divided into antibiotic
& antibacterial drugs, vitamin & dietary supplements, antacids &
anti-flatulent preparations, cardiac therapy drugs, and other applications. The
antibiotic & antibacterial drugs segment dominated the global market in
2017 and is anticipated to continue this dominance throughout the forecast
period. However, the vitamin & dietary supplements segment is expected to
grow at the fastest pace throughout the forecast period. Consumption of
antibiotics has considerably increased in the recent years. Increasing
consumption of antibiotics, either prescription or over-the-counter, has
resulted in incessant use of antibiotics for the treatment of ailments across
the globe.
The Asia-Pacific region is expected to witness the highest growth rate
throughout the forecast period, owing to its high population base, increase in
disposable incomes, improvement in patient awareness toward chronic disorders,
and adoption of a healthy lifestyle. In addition, countries, such as India and
China, serve as major contributors to the growth of the Asia-Pacific empty
capsules market, owing to the continuously evolving pharmaceutical industry in
these countries.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/985
The Major Key Players Are:
ACG Worldwide, Bright Pharma Caps Inc., CapsCanada Corporation, Lonza
Group Ltd. (Capsugel), Medi-Caps Ltd., Mitsubishi Chemical Holdings Corporation
(Qualicaps, Inc.), Roxlor LLC, Snail Pharma Industry Co. Ltd, Suheung Co., Ltd,
and Sunil Healthcare Ltd.
The other prominent players Are:
Patheon Ltd., Nectar Lifesciences Ltd., JC Biological Technologies,
Natural Capsules Ltd., Zhejiang Huili Capsules Co., Ltd., Healthcaps India
Limited, HTC Group Limited, and Nanjing Saturn Pharmaceutical Technology Co.,
Ltd.
